Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
AstraZeneca
Citi
Chinese Patent Office
Moodys
McKinsey
Deloitte
Cerilliant
Colorcon

Generated: December 11, 2017

DrugPatentWatch Database Preview

VEPESID Drug Profile

« Back to Dashboard

Which patents cover Vepesid, and what generic alternatives are available?

Vepesid is a drug marketed by Dava Pharms Inc and Corden Pharma and is included in two NDAs.

The generic ingredient in VEPESID is etoposide. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the etoposide profile page.
Drug patent expirations by year for VEPESID

Medical Subject Heading (MeSH) Categories for VEPESID

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Dava Pharms IncVEPESIDetoposideCAPSULE;ORAL019557-001Dec 30, 1986DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Dava Pharms IncVEPESIDetoposideCAPSULE;ORAL019557-002Dec 30, 1986DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Corden PharmaVEPESIDetoposideINJECTABLE;INJECTION018768-001Nov 10, 1983DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VEPESID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dava Pharms IncVEPESIDetoposideCAPSULE;ORAL019557-001Dec 30, 1986► Subscribe► Subscribe
Corden PharmaVEPESIDetoposideINJECTABLE;INJECTION018768-001Nov 10, 1983► Subscribe► Subscribe
Dava Pharms IncVEPESIDetoposideCAPSULE;ORAL019557-002Dec 30, 1986► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Moodys
Fuji
Healthtrust
Deloitte
McKesson
Fish and Richardson
Chinese Patent Office
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot